Concepedia

Elizabeth Comen

EC

Statistics

Publications

26

Citations

3.5K

H-Index

21

Active since

2004

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Cornell University

Eli Lilly (United States)

Cedars-Sinai Medical Center

The University of Texas MD Anderson Cancer Center

Elizabeth Comen is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, oncology, and molecular oncology.

ORCID

Publications per year

2004–2023

26

Publications

26

TOX is a critical regulator of tumour-specific T cell differentiation

Andrew Scott, Friederike Dündar, Paul Zumbo et al. · Nature · 2019 · 1.1K citations · Full text

, , +14

Tumor Entrained Neutrophils Inhibit Seeding in the Premetastatic Lung

Zvi Granot, Erik Henke, Elizabeth Comen et al. · Cancer Cell · 2011 · 783 citations · Full text

, , +14

A Pilot Study of Preoperative Single-Dose Ipilimumab and/or Cryoablation in Women with Early-Stage Breast Cancer with Comprehensive Immune Profiling

Heather L. McArthur, Adi Diab, David B. Page et al. · Clinical Cancer Research · 2016 · 224 citations · Full text

, , +17

MicroRNA-335 inhibits tumor reinitiation and is silenced through genetic and epigenetic mechanisms in human breast cancer

Kim J. Png, Mitsukuni Yoshida, Xiang H.-F. Zhang et al. · Genes & Development · 2011 · 219 citations · Full text

, , +17

Alterations in PTEN and ESR1 promote clinical resistance to alpelisib plus aromatase inhibitors

Pedram Razavi, Maura N. Dickler, Payal D. Shah et al. · Nature Cancer · 2020 · 162 citations

, , +10

1–5 of 26